CLEC-2 is required for development and maintenance of lymph nodes

被引:56
|
作者
Benezech, Cecile [1 ]
Nayar, Saba [1 ]
Finney, Brenda A. [2 ]
Withers, David R. [1 ]
Lowe, Kate [2 ]
Desanti, Guillaume E. [1 ]
Marriott, Clare L. [1 ]
Watson, Steve P. [2 ]
Caamano, Jorge H. [1 ]
Buckley, Christopher D. [1 ]
Barone, Francesca [1 ]
机构
[1] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England
[2] Univ Birmingham, Coll Med & Dent Sci, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
HIGH ENDOTHELIAL VENULES; FORMATION IN-VITRO; CELL-INTERACTIONS; RECEPTOR CLEC-2; PODOPLANIN; PLATELETS; VESSELS; VIVO; ORGANIZATION; VASCULATURE;
D O I
10.1182/blood-2013-03-489286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The importance of CLEC-2, a natural ligand/receptor for Gp38/Podoplanin, in the formation of the lymphatic vasculature has recently been demonstrated. As the development and maintenance of lymph nodes (LNs) is dependent on the formation of the lymphatic vasculature and the differentiation of Gp38/Podoplanin(+) stromal cells, we investigated the role of CLEC-2 in lymphoneogenesis and LN homeostasis. Using constitutive Clec1b(-/-) mice, we showed that while CLEC-2 was not necessary for initiation of the LN anlage, it was required at late stages of development. Constitutive deletion of CLEC-2 induced a profound defect in lymphatic endothelial cell proliferation, resulting in lack of LNs at birth. In contrast, conditional deletion of CLEC-2 in the megakaryocyte/platelet lineage in Clec1b(fl/fl) PF4-Cre mice led to the development of blood-filled LNs and fibrosis, in absence of a proliferative defect of the lymphatic endothelial compartment. This phenotype was also observed in chimeric mice reconstituted with Clec1b(fl/fl) PF4-Cre bone marrow, indicating that CLEC-2 expression in platelets was required for LN integrity. We demonstrated that LNs of Clec1b(fl/fl) PF4-Cre mice are able to sustain primary immune responses but show a defect in immune cell recirculation after repeated immunizations, thus suggesting CLEC-2 as target in chronic immune response.
引用
收藏
页码:3200 / 3207
页数:8
相关论文
共 50 条
  • [21] CLEC-2 activates Syk through dimerization
    Hughes, Craig E.
    Pollitt, Alice Y.
    Mori, Jun
    Eble, Johannes A.
    Tomlinson, Michael G.
    Hartwig, John H.
    O'Callaghan, Christopher A.
    Fuetterer, Klaus
    Watson, Steve P.
    BLOOD, 2010, 115 (14) : 2947 - 2955
  • [22] Structure and function of the activating receptor CLEC-2
    O'Callaghan, Chris A.
    Watson, Aleksandra A.
    Fenton-May, Angharad E.
    Christou, Charita M.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [23] A role of CLEC-2 in tumor growth and metastasis
    Shirai, T.
    Inoue, O.
    Hirayama, K.
    Endo, H.
    Fujii, H.
    Utida-Sato, H.
    Ozaki, Y.
    Suzuki-Inoue, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 139 - 139
  • [24] The Role of CLEC-2 and Its Ligands in Thromboinflammation
    Meng, Danyang
    Luo, Man
    Liu, Beibei
    FRONTIERS IN IMMUNOLOGY, 2021, 12 : 688643
  • [25] Cancellation of the Calcification in Cultured Osteoblasts by CLEC-2
    Kanai, Takenori
    Sawa, Yoshihiko
    Sato, Yoshiaki
    JOURNAL OF HARD TISSUE BIOLOGY, 2021, 30 (01) : 53 - 61
  • [26] GPVI and CLEC-2 in hemostasis and vascular integrity
    Watson, S. P.
    Herbert, J. M. J.
    Pollitt, A. Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (07) : 1457 - 1467
  • [27] The Platelet Receptor CLEC-2 Is Active as a Dimer
    Watson, Aleksandra A.
    Christou, Charita M.
    James, John R.
    Fenton-May, Angharad E.
    Moncayo, Gerald E.
    Mistry, Anita R.
    Davis, Simon J.
    Gilbert, Robert J. C.
    Chakera, Aron
    O'Callaghan, Chris A.
    BIOCHEMISTRY, 2009, 48 (46) : 10988 - 10996
  • [28] The novel platelet activation receptor CLEC-2
    Suzuki-Inoue, Katsue
    Inoue, Osamu
    Ozaki, Yukio
    PLATELETS, 2011, 22 (05) : 380 - 384
  • [29] Structure and function of the CLEC-2 receptor and its ligands
    Watson, A. A.
    Christou, C. M.
    Fenton-May, A. E.
    O'Callaghan, C. A.
    IMMUNOLOGY, 2008, 125 : 13 - 13
  • [30] Fucoidan Is a Novel Platelet Agonist for CLEC-2 Receptor
    Manne, Bhanukanth
    Getz, Todd M.
    Hughes, Craig
    Dangelmaier, Carol T.
    Watson, Steve P.
    Kunapuli, Satya P.
    BLOOD, 2012, 120 (21)